Vanguard Group
MDVX

Vanguard Group’s Medovex Corp. Common Stock MDVX Stock Holding History

Vanguard Group’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-32,705
Closed -$36K – 4118
2017
Q3 		$36K Hold
32,705
– – ﹤0.01% 4040
2017
Q2 		$29K Sell
32,705
-5,893
-15% -$6.88K ﹤0.01% 4055
2017
Q1 		$59K Buy
38,598
+200
+0.5% +$250 ﹤0.01% 4017
2016
Q4 		$51K Buy
38,398
+23,510
+158% +$34.9K ﹤0.01% 4030
2016
Q3 		$21K Hold
14,888
– – ﹤0.01% 4069
2016
Q2 		$20K Buy
+14,888
New +$20.2K ﹤0.01% 4116

Vanguard Group's MDVX Position: Q4 2017 in Review

Vanguard Group sold out of Medovex Corp. Common Stock (MDVX) in Q4 2017, closing a stake of 32,705 shares — an estimated $36K sold.

Vanguard Group first reported a position in MDVX in Q2 2016 and held it in 6 quarters. The position peaked at $59K in Q1 2017. 0 funds tracked by Wall St. Rank hold MDVX as of Q4 2017.

  • Vanguard Group reported no remaining Medovex Corp. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Vanguard Group sold 32,705 Medovex Corp. Common Stock shares in Q4 2017, an estimated $36K.
  • Vanguard Group first reported a position in Medovex Corp. Common Stock in Q2 2016 and held it in 6 quarters.
  • Vanguard Group's Medovex Corp. Common Stock position peaked at $59K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.